Ying Kuen (Ken) Cheung, PhD, is a biostatistician in the Office of Clinical Research (OCR) at the National Institute for Neurological Disorders and Stroke.His research interests include the design and analysis of clinical trials in stroke, neurological disorders, and cancer, and the development of behavioral intervention program in randomized community-based studies. His recent focus is the use of novel adaptive designs in early-phase clinical trials. Dr. Cheung is the statistician of several stroke and ALS trials, including NeuSTART (an early-phase development program of high-dose lovastatin for recovery from acute ischemic stroke) and a drug combination selection trial in ALS patients. He is the recipient of an R01 for methodology development of dose and selection designs in clinical trials.
He joined Columbia University in 2000 after earning his PhD in Statistics at the University of Wisconsin—Madison. He is a tenured associate professor of Biostatistics at the Mailman School of Public Health at Columbia University, and joins the OCR through an Intergovernmental Personnel Act Agreement.
Last Modified January 11, 2011